Search This Blog

Friday, August 15, 2025

Wave Life Sciences gains as JPMorgan suspends rating

 

  • Wave Life Sciences (NASDAQ:WVE) quickly hit highs of the day, rising 5%, after JPMorgan suspended its rating, price target, and estimates on the company. 
  • Some investors may be speculating that JPMorgan suspended its rating because it's advising the company on some type of transaction. 

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.